Icon is a clinical research organization. Co. operates as one business segment, which is the provision of outsourced development services on a global basis to the pharmaceutical, biotechnology and medical devices industries. Co. provides a range of clinical, consulting and commercial services that range from clinical development strategy, planning and trial design, to full study execution, and post-market commercialization. Co. engages in the development, management and analysis of programs that support various stages of the clinical development process. Co. provides services including clinical trial management, consulting, contract staffing and laboratory services. The ICLR stock yearly return is shown above.
The yearly return on the ICLR stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2019 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the ICLR annual return calculation with any dividends reinvested as applicable (on ex-dates).
|